Atrial fibrillation with or without valvular disease: is the prognosis different?

被引:0
|
作者
Mazzone, C. [1 ]
Barbati, G. [1 ]
Carriere, C. [2 ]
Cherubini, A. [1 ]
Faganello, G. [1 ]
Cioffi, G. [3 ]
Tarantini, L. [4 ]
Poli, S. [2 ]
Sinagra, G. [2 ]
Di Lenarda, A. [1 ]
机构
[1] ASS 1 Trieste, Cardiovasc Ctr, Trieste, Italy
[2] Univ Hosp Riuniti, Cardiovasc Dept, Trieste, Italy
[3] Villa Bianca Hosp, Trento, Italy
[4] San Martino Hosp, Belluno, Italy
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P5297
引用
收藏
页码:907 / 907
页数:1
相关论文
共 50 条
  • [41] Impact of Body Mass Index on the Prognosis of Japanese Patients With Non-Valvular Atrial Fibrillation
    Inoue, Hiroshi
    Kodani, Eitaro
    Atarashi, Hirotsugu
    Okumura, Ken
    Yamashita, Takeshi
    Origasa, Hideki
    AMERICAN JOURNAL OF CARDIOLOGY, 2016, 118 (02): : 215 - 221
  • [42] Relationship between valvular structure and biochemical indices of non-valvular atrial fibrillation and senile degenerative valvular heart disease
    Chen, Jian-Qin
    Zeng, Xin
    Li, Kun-Con
    Huang, Jing-Long
    Guo, Bing-Li
    Zhou, Xuan
    JOURNAL OF THORACIC DISEASE, 2023, 15 (02) : 611 - 619
  • [43] Optimal Anticoagulation Therapy in Patients With Valvular Heart Disease or Atrial Fibrillation Reply
    Torn, Marieke
    Rosendaal, Frits R.
    ARCHIVES OF INTERNAL MEDICINE, 2009, 169 (21) : 2033 - 2033
  • [44] Clinical Characteristics in Senile Degenerated Heart Valvular Disease Complicated with Atrial Fibrillation
    Tan, Y.
    Qiu, J.
    Yi, R. L.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2016, 64 : S327 - S327
  • [45] Oral anticoagulants in atrial fibrillation with valvular heart disease and bioprosthetic heart valves
    Malik, Aaqib H.
    Yandrapalli, Srikanth
    Aronow, Wilbert S.
    Panza, Julio A.
    Cooper, Howard A.
    HEART, 2019, 105 (18) : 1432 - 1436
  • [46] Outcomes of Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Valvular Heart Disease
    Dawwas, Ghadeer K.
    Barnes, Geoffrey D.
    CURRENT CARDIOLOGY REPORTS, 2022, 24 (06) : 731 - 738
  • [47] IDENTIFICATION OF A MICRORNA SIGNATURE FOR PREDICTING ATRIAL FIBRILLATION IN PATIENTS WITH VALVULAR HEART DISEASE
    Sharma, Param P.
    Sathipati, Srinivasulu Yerukala
    Shukla, Sanjay
    Carter, Tonia
    Soodi, Deepa
    Nwaedozie, Somto Tagbo
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 2185 - 2185
  • [48] Atrial Fibrillation in Valvular Heart Disease: Assessing the Impact of Genetics in the UK Biobank
    Cristin, Luca
    Tang, Janet
    Tastet, Lionel
    Marcus, Gregory
    Delling, Francesca
    CIRCULATION, 2024, 150
  • [49] Outcomes of Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Valvular Heart Disease
    Ghadeer K. Dawwas
    Geoffrey D. Barnes
    Current Cardiology Reports, 2022, 24 : 731 - 738
  • [50] Left atrial cardiomyopathy is a progressive disease accelerated by atrial fibrillation: comparison between patients with and without atrial fibrillation
    Mahnkopf, C.
    Mitlacher, M.
    Busch, S.
    Fischer, T.
    Brachmann, J.
    Forkmann, M.
    EUROPEAN HEART JOURNAL, 2018, 39 : 403 - 403